近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1. Ren, W. * , Xu, Z. * , Chang, Y. * , Ju, F. * , Wu, H. * , Liang, Z. * ,
Zhao, M., Wang, N., Lin, Y., Xu, C., Chen, S., Rao, Y., Lin, C., Yang, J, Liu,
P. # , Zhang, J. # , Huang, C. # & Xia, N. # Pharmaceutical targeting of OTUB2
sensitizes tumors to cytotoxic T cells via degradation of PD-L1. Nature
Communication s 15, 9, doi: 10.1038/s41467-023-44466-7 (2024).（ # 共通讯作者）
2. Lin, C. * , Teng, W. * , Tian, Y. * , Li, S., Xia, N. # & Huang, C. # The
immune landscape and response to oncolytic virus-based immunotherapy. Frontiers
of Medicine , https://doi.org/10.1007/s11684-023-1048-0 (2024). （ # 共通讯作者）
3. Wang, G. * , Cao, J. * , Gui, M. * , Huang, P. * , Zhang, L. * , Qi, R.,
Chen, R., Lin, L., Han, Q., Lin, Y., Chen, T., He, P., Ma, J., Fu, R., Hong, J.,
Wu, Q., Yu, H., Chen, J., Huang, C. # , Zhang, T. # , Yuan, Q. # , Zhang, J. # ,
Chen, Y. # & Xia, N. # The potential of swine pseudorabies virus attenuated
vaccine for oncolytic therapy against malignant tumors. J Exp Clin Cancer Res
42, 284, doi:10.1186/s13046-023-02848-1 (2023).（ # 共通讯作者）
4. Tian, R. * , Ju, F. * , Yu, M. * , Liang, Z., Xu, Z., Zhao, M., Qin, Y., Lin,
Y., Huang, X., Chang, Y., Li, S., Ren, W., Lin, C., Xia, N. & Huang, C. # A
potent neutralizing and protective antibody against a conserved continuous
epitope on HSV glycoprotein D. Antiviral Res 201, 105298,
doi:10.1016/j.antiviral.2022.105298 (2022).（ # 通讯作者）
5. Ju, F. * , Luo, Y. * , Lin, C. * , Jia, X. * , Xu, Z., Tian, R., Lin, Y.,
Zhao, M., Chang, Y., Huang, X., Li, S., Ren, W., Qin, Y., Yu, M., Jia, J., Han,
J., Luo, W., Zhang, J., Fu, G. # , Ye, X. # , Huang, C. # & Xia, N. # Oncolytic
virus expressing PD-1 inhibitors activates a collaborative intratumoral immune
response to control tumor and synergizes with CTLA-4 or TIM-3 blockade. J
Immunother Cancer 10, doi:10.1136/jitc-2022-004762 (2022).（ # 共通讯作者）
6. Luo, Y. * , Lin, C. * , Zou, Y., Ju, F., Ren, W., Lin, Y., Wang, Y., Huang,
X., Liu, H., Yu, Z., Liu, P., Tan, G., Yuan, Q., Zhang, J., Huang, C. # & Xia,
N. # Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine
responses to tumor antigens. Oncoimmunology 9, 1726168,
doi:10.1080/2162402X.2020.1726168 (2020).（ # 共通讯作者）
7. Lin, C. * , Ren, W. * , Luo, Y., Li, S., Chang, Y., Li, L., Xiong, D., Huang,
X., Xu, Z., Yu, Z., Wang, Y., Zhang, J., Huang, C. # & Xia, N. # Intratumoral
Delivery of a PD-1-blocking scFv encoded in Oncolytic HSV-1 Promotes Antitumor
Immunity and Synergizes with TIGIT Blockade. Cancer Immunol Res ,
doi:10.1158/2326-6066.CIR-19-0628 (2020).（ # 共通讯作者）
8. Lin, C., Li, H., Hao, M., Xiong, D., Luo, Y., Huang, C. # , Yuan, Q., Zhang,
J. & Xia, N. # Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome
Editing of HSV-1 Virus in Human Cells. Sci Rep 6, 34531, doi:10.1038/srep34531
(2016).（ # 共通讯作者）
9. Huang, C. H. * , Yuan, Q. * , Chen, P. J., Zhang, Y. L., Chen, C. R., Zheng,
Q. B., Yeh, S. H., Yu, H., Xue, Y., Chen, Y. X., Liu, P. G., Ge, S. X., Zhang,
J. # & Xia, N. S. # Influence of mutations in hepatitis B virus surface protein
on viral antigenicity and phenotype in occult HBV strains from blood donors. J
Hepatol 57, 720-729, doi:10.1016/j.jhep.2012.05.009 (2012).（ * 共第一作者）
10. Geng, X. * , Huang, C. * , Qin, Y., McCombs, J. E., Yuan, Q., Harry, B. L.,
Palmer, A. E., Xia, N. S. # & Xue, D. # Hepatitis B virus X protein targets
Bcl-2 proteins to increase intracellular calcium, required for virus replication
and cell death induction. Proc Natl Acad Sci U S A 109, 18471-18476,
doi:10.1073/pnas.1204668109 (2012).（ * 共第一作者）
京公网安备 11010802027423号